Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal Buprenorphine for Radiation-Induced Mucositis Pain
NCT04752384Phase 2Completed
- Sponsor
- Medical College of Wisconsin
- Start
- Jul 2021
- Primary completion
- Apr 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of buprenorphine in radiation-induced mucositis (RIOM), sponsored by Medical College of Wisconsin. Started Jul 2021; status: completed.
02
Drugs
buprenorphine
03
Conditions
radiation-induced mucositis (RIOM)
Beyond the preview
Go deeper on NCT04752384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04752384.